Advertisement

Topics

Sterile Water For Injection, USP Pharmacy Bulk Package Not for Direct Infusion VIAFLEX Plastic Container | Sterile Water [Baxter Healthcare Company] | BioPortfolio

13:48 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Sterile Water for Injection, USP is sterile, nonpyrogenic, distilled water in a Pharmacy Bulk Package. A Pharmacy Bulk Package is a container of a sterile preparation for parenteral use that contains many single doses. The contents are intended for use in a pharmacy admixture program and are restricted to the preparation of admixtures for intravenous infusion. No antimicrobial or other substance has been added. pH 5.5 (5.0 to 7.0). Osmolarity O mOsmol/L (calc.).

The VIAFLEX plastic container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). Exposure to temperatures above 25°C/77°F during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period. The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials.

Sterile Water for Injection, USP is used for fluid replacement only after suitable admixing to approximate isotonicity.

Sterile Water for Injection, USP is indicated in the aseptic preparation of parenteral admixtures.

Sterile Water for Injection, USP is a hemolytic agent due to its hypotonicity. Therefore, it is contraindicated for intravenous administration without admixing.

This solution is for compounding only, not for direct infusion. Hemolysis may occur following infusion of Sterile Water for Injection, USP.  Hemoglobin induced renal failure has been reported following hemolysis.

WARNING: This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum.

Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 µg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.

Do not use unless solution is clear and seal is intact.

Drug product contains no more than 25 µg/L of aluminum.

Safety and effectiveness have been established in pediatric patients. However, in neonates or very small infants the volume of fluid may affect fluid and electrolyte balance.

The administration of a suitable admixture of prescribed drugs may be associated with adverse reactions because of the solution or the technique of administration including febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.

Following suitable admixture of prescribed drugs, the dosage is usually dependent upon the age, weight and clinical condition of the patient as well as laboratory determinations. See directions accompanying drugs.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Use of a final filter is recommended during administration of all parenteral solutions where possible.

Sterile Water for Injection, USP in the Pharmacy Bulk Package is intended for use in the preparation of sterile, intravenous admixtures. Additives may be incompatible with the fluid withdrawn from this container. Complete information is not available. Those additives known to be incompatible should not be used. Consult with pharmacist, if available. When compounding admixtures, use aseptic technique. Mix thoroughly. Do not store any unused portion of Sterile Water for Injection, USP.

Tear overwrap down side at slit and remove solution container. Visually inspect the container. If the outlet port protector is damaged, detached, or not present, discard container as solution path sterility may be impaired. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly, if leaks are found, discard solution as sterility may be impaired.

For compounding only, not for direct infusion.

Sterile Water for Injection, USP is supplied in a VIAFLEX plastic Pharmacy Bulk Package container as follows:

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25°C/77°F).

Baxter Healthcare Corporation Deerfield, IL 60015 USA

Printed in USA

Baxter, Viaflex, and PL 146 are trademarks of Baxter International Inc.

07 19 73 676

Rev. September 2014

Distributed in Canada by Baxter Corporation Mississauga, ON L5N 0C2

2000 mL 2B0306 NDC 0338-0013-06
3000 mL 2B0307 NDC 0338-0013-08
5000 mL 2B0309 NDC 0338-0013-29

Container Label

LOT EXP

2B0306 2000 mL NDC 0338-0013-06 DIN 02014882

Sterile Water For Injection USP

Pharmacy Bulk Package Not For Direct Infusion

Rx Only

NO ANTIMICROBIAL OR OTHER SUBSTANCE HAS BEEN ADDEDpH 5.5 (5.0 TO 7.0) OSMOLARITY 0 mOsmol/L (CALC)STERILE NONPYROGENIC

CONTAINS NO MORE THAN 25 μg/L OF ALUMINUM

ADDITIVES MAY BE INCOMPATIBLE WITH THE FLUIDWITHDRAWN FROM THIS CONTAINER CONSULT WITHPHARMACIST IF AVAILABLE WHEN COMPOUNDINGADMIXTURES USE ASEPTIC TECHNIQUEMIX THOROUGHLY DO NOT STORE

DOSAGE ADMIX FOR INTRAVENOUS ADMINISTRATIONAS DIRECTED BY A PHYSICIAN SEE ACCOMPANYINGDIRECTIONS FOR USE ONCE CONTAINER CLOSURE HAS BEEN PENETRATED WITHDRAWAL OF CONTENTS SHOULD BE COMPLETED WITHOUT DELAY AFFIX ACCOMPANYING LABEL FOR DATE AND TIME OF ENTRY DISPENSE CONTENTS WITHIN 4 HOURS AFTER INITIAL ENTRY

CAUTIONS SQUEEZE AND INSPECT INNER BAG WHICHMAINTAINS PRODUCT STERILITY DISCARD IF LEAKS ARE FOUND DO NOT USE UNLESS SOLUTION IS CLEAR AND SEAL IS INTACT

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT ROOM TEMPERATURE (25°C/77°F) UNTIL READY TO USE AVOID EXCESSIVE HEAT SEE INSERT

VIAFLEX CONTAINER PL 146 PLASTIC

Baxter logo

BAXTER HEALTHCARE CORPORATION DEERFIELD IL 60015 USA

MADE IN USA

DISTRIBUTED IN CANADA BY BAXTER CORPORATION MISSISSAUGA ON L5N 0C2

BAXTER PL 146 AND VIAFLEX ARE TRADEMARKS OF BAXTER INTERNATIONAL INC

1800

1600

1400

1200

1000

800

600

400

200

07-25-69-275/07-25-34-056

Carton Label

2B0306 6 - 2000 ML VIAFLEX CONTAINER

STERILE WATER FOR INJECTION, USP FOR DRUG DILUENT USE ONLY

EXPXXXXX

SECONDARY BAR CODE

(17) YYMM00 (10) XXXXX

LOTXXXXX

PRIMARY BAR CODE

(01) 50303380013062

Manufacturer

Baxter Healthcare Company

Active Ingredients

Source

Drugs and Medications [134 Associated Drugs and Medications listed on BioPortfolio]

Lumigan [allergan, inc.]

Lumigan 03

Fomepizole [sandoz inc. ]

Rx only Sterile Caution: Must be diluted prior to use.

Greenglo [hub pharmaceuticals, inc.]

Green Glo (Lissamine Green)

Ful-glo [akorn, inc.]

Fluorescein Sodium Ophthalmic Strips, USP

Zymar [allergan, inc.]

Zymar

Clinical Trials [1229 Associated Clinical Trials listed on BioPortfolio]

Test for Preoperative Skin Preparations

Compare 2 application techniques of ChloraPrep Swabstick--3 swabsticks at once versus 3 swabsticks used one-at-a-time. Hibiclens applied according to the manufacturer's directions. Sterile...

Water And Saline Head-to-head In The Blinded Evaluation Study Trial

Patients who are diagnosed with acute appendicitis consented and then randomized into two arms of the trial. In one arm, patients receive irrigation of the abdomen during surgery with norm...

Subcutaneous Sterile Water Injection for Relief of Low Back Pain

To compare the effect of subcutenous sterile water injection technique with the subcutaneous saline injection technique in the degree and duration of low back pain-relieving during childbi...

Pharmacokinetic Study of Advate Reconstituted in 2 mL Sterile Water for Injection

The purpose of this study is to determine the pharmacokinetics and safety of rAHF-PFM reconstituted in 2 mL sterile water for injection (SWFI) and compare with those of rAHF-PFM reconstitu...

Zero Sodium Peritoneal Dialysate Protocol Pilot Study

The following pilot study will be undertaken to determine the effects of use of a zero-sodium peritoneal dialysate solution (10% dextrose in sterile water) on sodium removal as compared to...

PubMed Articles [6226 Associated PubMed Articles listed on BioPortfolio]

Knowledge and use of sterile water injections amongst midwives in the United Kingdom: A cross-sectional study.

The use of sterile water injections (SWI) for the relief of pain in labour is popular amongst midwives in countries such as Sweden and Australia. Anecdotal reports suggest the procedure is used less c...

Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes.

The purpose of this study was to evaluate the stability of vitamin K1 oral liquids in Sterile Water for Injection when stored in amber glass bottles and amber plastic syringes under refrigerated condi...

Investigation and Evaluation of Potential Aerosol Release by Maquet/Getinge Heater-Cooler Units Used during Cardiac Surgery.

 Heater-Cooler units (HCUs) supply tempered water through blood heat exchangers and through warming/cooling blankets to control the body temperature of heart surgery patients. Bacteria which potenti...

In vitro effect of 20% N-acetylcysteine on the viscosity of normal canine bile.

OBJECTIVE To evaluate the in vitro effect of 20% N-acetylcysteine (NAC) on the viscosity of normal canine bile. ANIMALS Bile samples obtained from 10 adult dogs euthanized for reasons unrelated to bil...

The work of sterile processing departments: An exploratory study using qualitative interviews and a quantitative process database.

The sterile processing of surgical instruments and equipment is an essential part of surgical operations. Although clean instruments prevent infections, little is known about the departments that cond...

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record